coronavirus vaccine
People with Severe Allergies Told to Avoid Pfizer/BioNTech COVID Vaccine
While rare, allergic reactions to vaccines can happen – and people with a history of allergies would not have been recruited for the trials.
Rudy Giuliani Hospitalized for COVID After Maskless Election-Conspiracy Tour
“Get better soon Rudy, we will carry on!!!” President Trump tweeted.
The Card You'll Be Given After Your COVID-19 Vaccine in the UK
As many as 4,000,000 could get the jab before the end of the year, resulting in "big patches of normality" soon.
Uber Is Asking the CDC to Give Drivers Priority Vaccine Access
Both public transit and ride-hail have seen a drop in demand due to COVID-19, and priority vaccine access would give Uber an edge.
Calm Down: You Won't Need a 'Vaccine Passport' to Go to the Pub
"That's not the plan," says Michael Gove.
Covid Vaccine Trial Successes Lifted Hopes Globally. Here's Why Vietnam Barely Blinked.
Countries ravaged by coronavirus may see a vaccine as a silver bullet, but Vietnam’s containment of the pandemic means it doesn’t need to hurry.
Dolly Parton Helped Make the New Coronavirus Vaccine Possible
With her April donation to the Vanderbilt Medical Center, the country icon continues to be a wholesome and unstoppable force for good.
I Can't Donate Plasma to COVID Research Because I Had Sex with a Man 3 Years Ago
The 22-year-old's case has provoked a human rights debate in the Netherlands.
The Trump Admin Is Blocking the FDA's Guidelines for a Safer COVID Vaccine
The White House is blocking stronger standards for the vaccine that would delay its approval until after Election Day.
The Number of Americans Planning to Get a COVID Vaccine Right Away Has Plummeted
And almost a quarter of respondents in a new poll say they'll never take it.
Rich Countries Have Already Bought More Than Half of Future Supply of COVID-19 Vaccines
They represent just 13 percent of the world population, an Oxfam study reveals.
EU Hopes for First Batch of Potential Coronavirus Vaccine By End of 2020
The manufacturer is trialling the drug on 50,000 people worldwide, and says it could have enough data to submit the potential vaccine to regulators by October.